Technical Analysis for HKMPF - Hikma Pharmaceutical

Grade Last Price % Change Price Change
grade A 25.15 0.60% 0.1500
HKMPF closed up 0.6 percent on Thursday, September 19, 2019, on 25 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A Up Up
See historical HKMPF trend table...

Date Alert Name Type % Chg
Pocket Pivot Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Stochastic Reached Overbought Strength 0.00%
BB Squeeze Ended Range Expansion 0.00%
Gapped Up Strength 0.00%
Overbought Stochastic Strength 0.00%
Bollinger Band Squeeze Range Contraction 0.60%
Narrow Range Bar Range Contraction 0.60%
Gapped Up Strength 0.60%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 4.79%

Older signals for HKMPF ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Hikma Pharmaceuticals PLC develops, manufactures, and markets a range of generic, branded, and in-licensed pharmaceutical products in solid, semi-solid, liquid, and injectable final dosage forms. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment manufactures, markets, and sells generic injectable products for therapeutic categories, including anti-infective, anaesthetic, central nervous system (CNS), oncology, and pain management, as well as controlled substances and cardiovascular products. The Generics segment develops and sells approximately 100 oral and other non-injectable generic products for oncology and pain management, as well as respiratory, nasal spray, suspension, liquid solution, and high-containment areas. The Branded segment develops, manufactures, and markets branded generics and in-licensed products, such as anti-infective products, as well as chronic therapeutic categories comprising cardiovascular, diabetes, CNS, and oncology products. The company also manufactures plastic specialized medicinal sterile containers and APIs; and conducts bio-equivalency studies. It operates in the United Kingdom, the United States, the Middle East, North Africa, Europe, and internationally. The company was founded in 1978 and is based in London, the United Kingdom.
Health Diabetes Pharmaceutical Industry In China Pain Pain Management Pharmaceutical Companies Anti Infective Products Cardiovascular Products Generic Injectable Products Hikma Pharmaceuticals Lupin Limited Oncology Products
Is HKMPF a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 35.25
52 Week Low 12.0
Average Volume 3,238
200-Day Moving Average 0.0
50-Day Moving Average 23.2621
20-Day Moving Average 23.424
10-Day Moving Average 24.338
Average True Range 0.7146
ADX 10.73
+DI 56.9532
-DI 41.5254
Chandelier Exit (Long, 3 ATRs ) 23.2562
Chandelier Exit (Short, 3 ATRs ) 23.0438
Upper Bollinger Band 25.9058
Lower Bollinger Band 20.9422
Percent B (%b) 0.85
BandWidth 21.190232
MACD Line 0.6246
MACD Signal Line 0.4362
MACD Histogram 0.1884
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 25.1500
Resistance 3 (R3) 25.1500 25.1500 25.1500
Resistance 2 (R2) 25.1500 25.1500 25.1500 25.1500
Resistance 1 (R1) 25.1500 25.1500 25.1500 25.1500 25.1500
Pivot Point 25.1500 25.1500 25.1500 25.1500 25.1500
Support 1 (S1) 25.1500 25.1500 25.1500 25.1500 25.1500
Support 2 (S2) 25.1500 25.1500 25.1500 25.1500
Support 3 (S3) 25.1500 25.1500 25.1500
Support 4 (S4) 25.1500